Drawing for SIMTRA

USPTO serial 98169997

SIMTRA

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
NGUYEN, CINDY EVANS
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with SIMTRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,545*

Plus Government fees of $750

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Salima A. Merani

Salima A. Merani Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614United States

Goods and services

ClassDescriptionStatusFirst use
001Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, infectious diseases, immune disorders, infertility, viruses, blood disorders, genetic disorders, digestive disorders, inflammation, diabetes-related conditions, viral conditions, metabolic conditions, endocrine conditions, musculoskeletal conditions, cardiovascular conditions, cardiopulmonary conditions, genitourinary conditions, sexual dysfunction, hepatological conditions, ophthalmic conditions, respiratory conditions, gastrointestinal conditions, hormonal conditions, degenerative disorders, and dermatological conditions; Chemical additives for use in the manufacture of pharmaceuticals; Chemical additives for use in the manufacture of a wide variety of goods; Chemical preparations for scientific purposes; Chemicals for use in industry and scienceACTIVE—
005Dermatologicals; Inhalers for medical purposes, sold filled with pharmaceutical preparations for treating respiratory disorders, infectious disorders, infertility, viruses, diabetes-related conditions, cancer, immune conditions and inflammation; Medicated cosmetics; Medicated dermatological preparations and substances; Pharmaceutical preparations for the treatment and prevention of cancer, infectious diseases, immune disorders, infertility, viruses, blood disorders, genetic disorders, digestive disorders, inflammation, diabetes-related conditions, viral conditions, metabolic conditions, endocrine conditions, musculoskeletal conditions, cardiovascular conditions, cardiopulmonary conditions, genitourinary conditions, sexual dysfunction, hepatological conditions, ophthalmic conditions, respiratory conditions, gastrointestinal conditions, hormonal conditions, degenerative disorders and dermatological conditions; Syringes sold filled with pharmaceutical preparations for treating respiratory disorders, infectious disorders, infertility, viruses, diabetes-related conditions, cancer, immune conditions and inflammationACTIVE—
040Custom manufacture of pharmaceuticals; Manufacturing services for others in the field of pharmaceuticals; Providing technical information in the field of pharmaceutical manufacturingACTIVE—
042Consulting services in the field of pharmaceutical research and development; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Testing of pharmaceuticalsACTIVE—
044Pharmaceutical advice; Pharmaceutical compounding services; Providing medical information to manufacturers in the form of reports in the field of manufacturing of active ingredients and scalingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 14, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 13, 2026EX4GSOU EXTENSION 4 GRANTED—
Aug 13, 2026EXT4SOU EXTENSION 4 FILED—
Aug 13, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 28, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 27, 2026EX3GSOU EXTENSION 3 GRANTED—
Jan 27, 2026EXT3SOU EXTENSION 3 FILED—
Jan 27, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 8, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 7, 2025EX2GSOU EXTENSION 2 GRANTED—
Aug 7, 2025EXT2SOU EXTENSION 2 FILED—
Aug 7, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 4, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 4, 2025EX1GSOU EXTENSION 1 GRANTED—
Feb 4, 2025EXT1SOU EXTENSION 1 FILED—
Feb 3, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 13, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 18, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 18, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 29, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 13, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 3, 2024DOCKASSIGNED TO EXAMINER—
Nov 20, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 7, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance